Reported by 5 physicians · state cohort · total comp, not the employer's posted pay
5 physician reports · not the employer's posted pay
This position is for a Medical Oncologist specializing in melanoma and sarcoma at the Baptist MD Anderson Cancer Center in Jacksonville, FL, supporting a multidisciplinary oncology program with academic and research involvement. The center is a state-of-the-art, hospital-based cancer facility affiliated with MD Anderson Cancer Center offering integrated multidisciplinary care and academic appointments.
SalaryDr summary based on the original posting
Physician-reported range shown; the employer did not post pay for this role.
This is a SalaryDr Signal computed from 5 recent, verified physician reports (state cohort). It is not an employer offer or posted pay; this employer did not disclose pay.
Claim this free profile to see who's viewing your roles and manage your listings.
SalaryDr will show local peer compensation and hiring supply here once this role has enough verified physician data.
Generated from this posting's disclosed facts and the SalaryDr comparison — bring them to the first recruiter call.
Baptist MD Anderson Center 1301 Palm Ave Jacksonville, Florida 32207 Location Overview Baptist Health partnered with MD Anderson Cancer Center in Houston to create the Baptist Health MD Anderson Cancer Center in Jacksonville. MD Anderson is the largest freestanding cancer center in the world, ranked as one of the top two hospitals in cancer care by U.S. News and World Report. Baptist Health of Northeast Florida provides state-of-the art care for all types of cancer and is a regional leader in prevention, diagnosis, treatment, research and education. Baptist MD Anderson resides ata 330,000 square foot patient-centered, state-of-the-art facility dedicated solely to the full spectrum of oncology care. As one of seven health systems in the nation and the only one in Southwest US to partner with MD Anderson Cancer Center, Baptist Health is replicating the MD Anderson model of care, with full clinical and operational integration. This means patients in the Southeast U.S. will be able to benefit from the same full range of multi-disciplinary care options as those available in Houston, including access to ongoing cancer research and select clinical trials.